Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million
Zydus Lifesciences plans to acquire Nasdaq-listed clinical-stage immuno-oncology firm Agenus’s two biologics manufacturing facilities in California, U.S. for $125 million to enter the global biologics contract development and manufacturing organization…
Ananda Pharma advances CBD drug with Phase 1 study listing
LONDON – Ananda Pharma PLC (AQSE:ANA), a UK-based biopharmaceutical company, has announced the publication of its Phase 1 pharmacokinetic study on the clinical trial registry clinicaltrials.gov, with the reference number…
With Advent of Level Playing Field, Domestic MedTech Industry exclaims ‘Eureka!’
AiMed showers unqualified praise on Government for jettisoning foreign favoritism New Delhi: Rajiv Nath, one of the greatest champions of Make in India and no nonsense leader of domestic medical…
Govt supports indigenous manufacturing of complex pharma excipients by Nitika Pharmaceutical Specialties
For commercial-scale production of 14 complex excipients The Technology Development Board (TDB), Department of Science and Technology (DST), Government of India has extended financial support to Nitika Pharmaceutical Specialties Private…
Medical representatives barred from govt hospitals to stop pharma influence
Medical representatives will no longer be permitted to meet doctors directly within central government hospitals, following a directive from the Centre aimed at putting an end to the nexus between…
Generic drugs can bring hope for SMA patients’
Dr Ann Agnes Mathew, a consultant paediatric neurologist and neuromuscular specialist based in Bengaluru, treats nearly 600 SMA patients from across India. In an interview with DH’s Udbhavi Balakrishna, she…
47% of pharma MOUs from VGGS 2024 commissioned
Gandhinagar: The state govt said that 47% of MoUs signed in the pharmaceutical sector in the Vibrant Gujarat Global Summit (VGGS) 2024 have been commissioned. It said on Friday that…
I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330
ICICI Securities has downgraded Aurobindo Pharma to Add (from Buy earlier) with a revised target price of Rs 1,330 (earlier Rs 1,445). The current market price of Aurobindo Pharma Ltd.…
AstraZeneca gets CDSCO nod for lung cancer drug
New Delhi: AstraZeneca India Pharma on Thursday said it has received approval from the government authority for the import, sale, and distribution of a medication used in treating non-small cell…
Anar Modi named CHO at Senores Pharma
Senores Pharma has named Anar Modi as the Chief Heart Officer (CHO) of its group. The announcement was made through a LinkedIn post, where the company stated, “We’re excited to…
